Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Op. Grant: Data Analysis Using Existing Databases and Cohorts-Infection/Immunity

Research Institute of the McGill University Health Centre

$75,000.00

Maternal pre-eclampsia and respiratory syncytial virus disease in infant

FY 2024-25

Summary
Respiratory syncytial virus (RSV) related hospitalization is the leading cause of infant hospitalization in Canada. Despite recent progress in vaccine efforts to prevent severe RSV infection, challenges remain in deciding which mother or infant to immunize and when. Identifying children at the highest risk of RSV hospitalization can help accelerate disease prevention efforts and reduce the burden of RSV, especially due as RSV immunization products may not be accessible to all infants. This study will investigate if children born of a pregnancy complicated by maternal pre-eclampsia are at greater risk of RSV hospitalization. Findings from this study will help inform future ways of identifying children (or mothers) at high risk of infant RSV, potentially enhancing targeted prevention.
Program
Op. Grant: Data Analysis Using Existing Databases and Cohorts-Infection/Immunity
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
522512
Name
Ukah Ugochinyere Viv
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Data Analysis Using Existing CDN Databases and Cohorts (2026)
Projecttitle
Maternal pre-eclampsia and respiratory syncytial virus disease in infant
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Op. Grant: Data Analysis Using Existing Databases and Cohorts-Infection/Immunity
Keyworddelim
Hypertensive Disorders Of Pregnancy; Pediatrics; Preeclampsia; Respiratory Syncytial Virus
Abstract
Respiratory syncytial virus (RSV) related hospitalization is the leading cause of infant hospitalization in Canada. Despite recent progress in vaccine efforts to prevent severe RSV infection, challenges remain in deciding which mother or infant to immunize and when. Identifying children at the highest risk of RSV hospitalization can help accelerate disease prevention efforts and reduce the burden of RSV, especially due as RSV immunization products may not be accessible to all infants. This study will investigate if children born of a pregnancy complicated by maternal pre-eclampsia are at greater risk of RSV hospitalization. Findings from this study will help inform future ways of identifying children (or mothers) at high risk of infant RSV, potentially enhancing targeted prevention.
Competitiondate
202410
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ukah, Ugochinyere Viv; Auger, Nathalie; Merckx, Joanna-Trees
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $75,000~ $0~